[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX365899B - Composición farmacéutica que comprende un fragmento de péptido de hmgb1 para usarse en tratamiento de daño a la medula espinal. - Google Patents

Composición farmacéutica que comprende un fragmento de péptido de hmgb1 para usarse en tratamiento de daño a la medula espinal.

Info

Publication number
MX365899B
MX365899B MX2015005253A MX2015005253A MX365899B MX 365899 B MX365899 B MX 365899B MX 2015005253 A MX2015005253 A MX 2015005253A MX 2015005253 A MX2015005253 A MX 2015005253A MX 365899 B MX365899 B MX 365899B
Authority
MX
Mexico
Prior art keywords
spinal cord
cord injury
novel method
treating spinal
hmgb1 fragment
Prior art date
Application number
MX2015005253A
Other languages
English (en)
Other versions
MX2015005253A (es
Inventor
Tamai Katsuto
Yamazaki Takehiko
Cui Wenhao
Original Assignee
Univ Osaka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka filed Critical Univ Osaka
Publication of MX2015005253A publication Critical patent/MX2015005253A/es
Publication of MX365899B publication Critical patent/MX365899B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica para usarse en el tratamiento de daño a la médula espinal, en donde la composición farmacéutica comprende un fragmento de péptido de HMGB1.
MX2015005253A 2012-10-25 2013-10-24 Composición farmacéutica que comprende un fragmento de péptido de hmgb1 para usarse en tratamiento de daño a la medula espinal. MX365899B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012235786 2012-10-25
PCT/JP2013/078759 WO2014065348A1 (ja) 2012-10-25 2013-10-24 Hmgb1断片を利用した脊髄の損傷に対する新規治療法

Publications (2)

Publication Number Publication Date
MX2015005253A MX2015005253A (es) 2015-10-29
MX365899B true MX365899B (es) 2019-06-19

Family

ID=50544721

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015005253A MX365899B (es) 2012-10-25 2013-10-24 Composición farmacéutica que comprende un fragmento de péptido de hmgb1 para usarse en tratamiento de daño a la medula espinal.

Country Status (18)

Country Link
US (1) US9688733B2 (es)
EP (1) EP2913059B1 (es)
JP (1) JP6253590B2 (es)
KR (1) KR102146822B1 (es)
CN (1) CN104955470B (es)
AU (1) AU2013335685B2 (es)
BR (1) BR112015008745B1 (es)
CA (1) CA2889299C (es)
DK (1) DK2913059T3 (es)
ES (1) ES2673861T3 (es)
HK (2) HK1212888A1 (es)
MX (1) MX365899B (es)
PL (1) PL2913059T3 (es)
RU (1) RU2649069C2 (es)
SG (1) SG11201503215XA (es)
TR (1) TR201807769T4 (es)
WO (1) WO2014065348A1 (es)
ZA (1) ZA201502829B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0911513A2 (pt) 2008-04-30 2016-07-12 Genomix Co Ltd métodos e agentes para coleta de células tronco da medula óssea funcionais in vivo com alta eficiência
DK3358011T3 (da) 2011-04-26 2020-05-11 Univ Osaka Peptid til inducering af regenerering af væv og anvendelse deraf
KR102146815B1 (ko) 2012-10-25 2020-08-21 가부시키가이샤 스템림 Hmgb1 단편을 이용한 신규 심근경색의 치료법
TWI805565B (zh) 2017-01-27 2023-06-21 日商斯德武利姆股份有限公司 心肌病、陳舊性心肌梗塞及慢性心臟衰竭的治療藥物
CN111542335A (zh) 2017-12-01 2020-08-14 斯特姆里姆有限公司 炎症性肠病的治疗药
EP3750553A4 (en) 2018-02-08 2022-01-12 Stemrim Inc. THERAPEUTIC FOR PSORIASIS
JP7405345B2 (ja) * 2018-10-05 2023-12-26 株式会社ステムリム 間葉系幹細胞の動員活性を有するペプチド
MX2021004758A (es) 2018-10-25 2021-08-24 Univ Osaka Agente terapeutico para el trastorno de cartilago.

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5238680B2 (es) 1972-12-27 1977-09-30
US5658894A (en) 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
US5661127A (en) 1995-05-01 1997-08-26 The Regents Of The University Of California Peptide compositions with growth factor-like activity
JP3018313B2 (ja) 1996-02-23 2000-03-13 雪印乳業株式会社 骨形成促進及び骨吸収防止剤
US20040031072A1 (en) 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
US6720340B1 (en) 1999-07-28 2004-04-13 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine receptor agonists in stem cell and progenitor cell recruitment
EP1114862A3 (de) 1999-11-17 2003-08-06 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen
WO2001062895A2 (en) 2000-02-24 2001-08-30 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
JP3421741B2 (ja) 2000-05-18 2003-06-30 筑波大学長 人工骨髄、血球細胞の増殖方法
ITMI20010562A1 (it) 2001-03-16 2002-09-16 Marco E Bianchi Inibitori o antagonisti della proteina hmg1 per il trattamento di disordini vascolari
DE10121254A1 (de) 2001-04-30 2002-11-07 Switch Biotech Ag MRP8/MRP14 Heterodimers oder seiner Einzelkomponenten alleine oder in Kombination zur Behandlung und/oder Prävention von Hauterkrankungen, Wunden und/oder Wundheilungsstörungen, die durch eine verringerte Menge an MRP8/MRP14 Heterodimeren gekennzeichnet sind
AU2002304710A1 (en) 2001-04-30 2002-11-11 Switch Biotech Ag Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
US7304034B2 (en) * 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
BR0209689A (pt) 2001-05-15 2006-02-07 Long Island Jewish Res Inst Uso de fragmento de hmg como agente anti-inflamatório
US7220723B2 (en) 2001-05-15 2007-05-22 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
ITMI20011986A1 (it) 2001-09-25 2003-03-25 San Raffaele Centro Fond Metodo e composizione per l'attivazione di cellule presentanti l'antigene
EP1459759A4 (en) 2001-11-19 2007-08-29 Kyowa Hakko Kogyo Kk MEDICAMENT FOR THE MOBILIZATION OF PLURIPOTENTIAL STEM CELLS FROM TISSUE IN THE PERIPHERAL BLOOD
EP2305276A3 (en) 2001-12-07 2011-09-21 Cytori Therapeutics, Inc. Processed lipoaspirate cells for use in therapy
KR20050054907A (ko) 2002-07-03 2005-06-10 폰다지오네 센트로 산 라파엘 델 몬테 테이보 조직 손상의 치료 및/또는 조직 회복의 촉진에서ｈｍｇｂ1 단백질의 용도
ATE427758T1 (de) 2002-07-05 2009-04-15 Univ Laval Inhibitor des chemotaktischen faktors zur hemmung der entzundungsreaktionen
GB0226251D0 (en) 2002-11-11 2002-12-18 San Raffaele Centro Fond Acetylated protein
NZ540067A (en) * 2002-11-20 2007-05-31 Critical Therapeutics Inc A purified preparation of antibodies that specifically bind to a high mobility group box protein (HMGB) B box but do not specifically to non-B box epitopes of HMGB
US20070154529A1 (en) 2003-01-03 2007-07-05 Alcedo Biotech Gmbh Uses of dna binding proteins
WO2004075855A2 (en) 2003-02-26 2004-09-10 Biomed Solutions, Llc Process for in vivo treatment of specific biological targets in bodily fluid
ATE411038T1 (de) 2003-03-28 2008-10-15 Univ Laval S100 protein als aktivator neutrophiler zellen zur verminderung der neutropenie bei der krebsbehandlung
US20050014255A1 (en) 2003-05-29 2005-01-20 Board Of Regents, The University Of Texas System Stem cells for clinical and commercial uses
WO2005025604A2 (en) 2003-09-10 2005-03-24 The General Hospital Corporation Use of hmgb and hmgb fragments to decrease specific immune response
ITRM20040058A1 (it) 2004-02-03 2004-05-03 Marco E Bianchi Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali.
AU2005264185A1 (en) 2004-07-20 2006-01-26 Centro Cardiologico Monzino S.P.A. - Irccs Use of HMGB1 for wound healing
MX2007001155A (es) 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
MX2007002557A (es) 2004-09-03 2007-10-10 Creabilis Therapeutics Spa Uso de polipeptidos obtenidos a traves de mutaciones sistematicas de aminoacidos unicos de bloque-a humano y no humano de hmgb1 para prevenir y/o antagonizar las patologias inducidas por hmgb1.
KR100593397B1 (ko) 2004-10-27 2006-06-28 한국원자력연구소 중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
WO2006047820A1 (en) 2004-11-01 2006-05-11 Newsouth Innovations Pty Limited Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation
ITRM20050032A1 (it) 2005-01-21 2006-07-22 Marco E Bianchi Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.
US9782439B2 (en) 2005-01-27 2017-10-10 Japan Health Sciences Foundation Cell sheet containing mesenchymal stem cells
BRPI0609573A2 (pt) 2005-03-23 2010-04-20 Biosafe Sa sistema integrado para coletar, processar e transplantar subconjuntos de células, incluindo células-tronco adultas, para medicina regenerativa
WO2006114805A2 (en) 2005-04-28 2006-11-02 Fondazione Centro San Raffaele Del Monte Tabor Use of hmgb2 and hmgb3 proteins for medical applications
WO2007015546A1 (ja) 2005-08-04 2007-02-08 Genomix Co., Ltd 間葉系幹細胞誘導剤及び組織再生促進剤並びに間葉系幹細胞の調製方法
WO2007031100A1 (en) 2005-09-14 2007-03-22 Ostini, Marco Active immunotherapy of life-threatening systemic inflammation
WO2007130725A2 (en) 2006-02-06 2007-11-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of hmgb1 for protection against ischemia reperfusion injury
JP4982739B2 (ja) 2006-06-01 2012-07-25 国立大学法人 東京医科歯科大学 ポリグルタミン病の予防・治療剤
US8496931B2 (en) 2006-08-11 2013-07-30 Medarex, Inc. Monoclonal antibodies against stromal derived factor-1 (SDF-1)
EP2055308B1 (en) * 2006-10-30 2017-05-10 Genomix Co., Ltd. Pharmaceutical for promoting functional regeneration of damaged tissue
BRPI0911513A2 (pt) 2008-04-30 2016-07-12 Genomix Co Ltd métodos e agentes para coleta de células tronco da medula óssea funcionais in vivo com alta eficiência
KR101728379B1 (ko) * 2008-04-30 2017-04-19 가부시키가이샤 제노믹스 말초 순환으로의 골수 유래 다능성 줄기세포 동원약
JP5814549B2 (ja) 2008-04-30 2015-11-17 株式会社ジェノミックス 損傷組織の機能的再生促進医薬
WO2011046570A1 (en) * 2009-10-16 2011-04-21 The University Of Medicine And Dentistry Of New Jersey Method for treating chronic nerve tissue injury using a cell therapy strategy
CA2778759A1 (en) 2009-10-28 2011-05-05 Genomix Co., Ltd. Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood
DK3358011T3 (da) 2011-04-26 2020-05-11 Univ Osaka Peptid til inducering af regenerering af væv og anvendelse deraf
CN102443064A (zh) 2011-11-03 2012-05-09 刘誉 一种基于凝血酶活性的双靶向作用的嵌合多肽及其应用
KR102146815B1 (ko) 2012-10-25 2020-08-21 가부시키가이샤 스템림 Hmgb1 단편을 이용한 신규 심근경색의 치료법

Also Published As

Publication number Publication date
ZA201502829B (en) 2020-11-25
SG11201503215XA (en) 2015-06-29
WO2014065348A1 (ja) 2014-05-01
ES2673861T3 (es) 2018-06-26
CA2889299C (en) 2023-02-14
MX2015005253A (es) 2015-10-29
RU2649069C2 (ru) 2018-04-02
KR102146822B1 (ko) 2020-08-21
HK1213201A1 (zh) 2016-06-30
PL2913059T3 (pl) 2018-09-28
BR112015008745A2 (pt) 2017-11-21
JP6253590B2 (ja) 2017-12-27
RU2015119523A (ru) 2016-12-20
US20150274792A1 (en) 2015-10-01
CN104955470A (zh) 2015-09-30
BR112015008745B1 (pt) 2022-08-02
AU2013335685A1 (en) 2015-05-14
JPWO2014065348A1 (ja) 2016-09-08
EP2913059A4 (en) 2016-03-30
KR20150102957A (ko) 2015-09-09
AU2013335685B2 (en) 2017-10-12
DK2913059T3 (en) 2018-06-25
CA2889299A1 (en) 2014-05-01
CN104955470B (zh) 2017-06-16
EP2913059A1 (en) 2015-09-02
HK1212888A1 (zh) 2016-06-24
US9688733B2 (en) 2017-06-27
EP2913059B1 (en) 2018-04-11
TR201807769T4 (tr) 2018-06-21

Similar Documents

Publication Publication Date Title
MX361259B (es) Uso de un fragmento de peptido hmgb1 para el tratamiento del infarto al miocardio.
MX2015005253A (es) Metodo novedoso para tratar el daño a la medula espinal utilizando el fragmento de hmgb1.
IL279330A (en) Combined treatment including antibodies against Claudin 18.2 for the treatment of cancer
IL276434A (en) Combined treatment involving antibodies against claudin 18.2 for the treatment of cancer
HK1213925A1 (zh) 用於治療癌症的涉及抗密蛋白 抗體的組合療法
BR112016018170A2 (pt) métodos para tratar doença de alzheimer
ME02932B (me) Kombinovana terapija koja uključuje antitela protiv klaudina 18.2 za lečenje kancera
EP2879705A4 (en) PEPTIDE VACCINES BASED ON THE EGFRVIII SEQUENCE FOR THE TREATMENT OF TUMORS

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: KUMIAI CHEMICAL INDUSTRY CO., LTD.

FG Grant or registration